Category: Minimal Residual Disease (MRD)
Tara Gregory, MD, Colorado Blood Cancer Institute, Denver, CO and Jay Spiegel, MD, Sylvester Comprehensive Cancer Center, Miami, FL
Rahul Banerjee, MD, FACP, Fred Hutchinson Cancer Center, Seattle, WA
Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY
Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY
Jeffrey L. Wolf, MD, University of California San Francisco, San Francisco, CA
Gail J. Roboz, MD, Weill Cornell Medical College, New York, NY